Authorities in the special municipality of the Isle of Youth, to the southwest of Cuba’s mainland, will ease COVID-19 restrictions as of July 21 given the low prevalence of the virus in the territory, but not disregarding epidemiological surveillance and safety protocols.

Alicia Barcena, executive secretary of the Economic Commission for Latin America and the Caribbean (ECLAC), highlighted Cuba's great resilience, despite being subjected for more than 60 years to the largest series of sanctions that the United States has applied to any country in the world.

A total of 2,109,050 Cubans have already completed the three-dose vaccination schedule of one of the vaccine candidates developed in the country against COVID-19.

Cuba studied 43,808 samples of COVID 19, resulting in 6,057 positive ones. The country accumulates 5, 950,808 samples taken and 294,449 positive.

The Abdala vaccine, obtained by the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym), will benefit pregnant women in the second and third trimester of gestation and infants, as well as people allergic to thiomersal in the coming months.

In the midst of an epidemiological context marked by the circulation of new strains in the country, there is evidence of an increase in the severity of COVID-19 in infected patients.

An agreement between the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym) and the University of Havana (UH) will allow the creation of a joint laboratory in Nanobiomedicine, for the execution of innovative projects linked to the design and production of drugs.

The Cuban Finlay Vaccine Institute highlighted the high safety level proven by clinical trials with the COVID-19 candidate vaccine Soberana 02 in Cuban children.

Two million 108 thousand 739 citizens in Cuba have already received all three doses of the locally developed COVID-19 vaccines which have immunized them against the virus.

A study carried out by professors from the Psychology Faculty of the University of Havana and supported by the United Nations Children's Fund ( UNICEF) office in Cuba revealed that due to the confinement in homes as a protection measure against COVID-19, children and adolescents on the island showed symptoms of psychological discomfort.

The application of the vaccine candidate Soberana Plus to 253 health workers who suffered from COVID-19, shows the progress of this intervention that covers 308 of those people in Villa Clara, as a guarantee for the protection of health workers in Cuba.

Cuba studied 44,310 samples for COVID 19, resulting in 6,505 positive ones. The country accumulates 5, 907,000,000 samples taken and 288,392 positive.

The statistical analysis of a larger volume of data revealed other favorable results of efficacy of the Cuban vaccine Abdala against symptomatic COVID-19, informed today Dr. Francisco Hernandez Bernal, chief monitor of the clinical studies with this immunogen of the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym).

The immunization against COVID-19 with the Abdala vaccine, developed by the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym), is expected to be completed later this month in Havana, said Dr. Marta Ayala Avila, director of that institution.